Yield Theory

Congressional trades by ticker

CRNX congressional trades

Crinetics Pharmaceuticals, Inc. - Common Stock appears in 5 verified House Clerk rows from Gilbert Cisneros and Josh Gottheimer across the 2025–2026 periodic reports. The table keeps disclosed owners and amount ranges; it is not a live CRNX portfolio.
Verified rows
5
Filers
2
Purchases
3
Latest trade
2026-07-30

Verified CRNX House disclosures

Parsed from official House Clerk periodic transaction reports. This snapshot contains 3 purchases and 2 sales. Reported owners: Self, Joint. Transaction dates run from 2025-01-29 to 2026-07-30.

PoliticianTrade dateAssetTypeOwnerAmountFiling
Gilbert CisnerosCrinetics Pharmaceuticals, Inc. - Common StockSaleSelf$15,001 - $50,000#20035190
Filed 2026-09-04
Gilbert CisnerosCrinetics Pharmaceuticals, Inc. - Common StockPurchaseSelf$1,001 - $15,000#20034285
Filed 2026-04-07
Gilbert CisnerosCrinetics Pharmaceuticals, Inc. - Common StockPurchaseSelf$1,001 - $15,000#20030288
Filed 2025-05-06
Josh GottheimerCrinetics Pharmaceuticals, Inc. - Common StockSaleJoint$1,001 - $15,000#20029083
Filed 2025-04-10
Gilbert CisnerosCrinetics Pharmaceuticals, Inc. - Common StockPurchaseSelf$1,001 - $15,000#20026726
Filed 2025-02-11

A filing can describe the member, a spouse, a dependent, or a joint asset. Amounts are statutory ranges, not execution prices. See how to read congressional stock-trade disclosures before treating a delayed row as a trading signal.

The filing is free

Keep the CRNX range and owner as filed. Membership adds the investment view around the money, not a list to copy.

Get this month’s call for $15

CRNX congressional trades — FAQ

Who in Congress traded CRNX?

House Clerk periodic reports for 2025 and 2026 contain 5 verified CRNX rows from 2 members: Gilbert Cisneros and Josh Gottheimer. Image-only filings are excluded, and this is not a live brokerage statement.

Does this page show current CRNX holdings?

No. STOCK Act filings disclose reportable transactions after the fact, usually within 45 days, as amount ranges and owners. They do not prove a current position, an exact share count, or why the trade happened.

Why are CRNX amounts shown as ranges?

House periodic transaction reports use statutory value bands such as $15,001 - $50,000; $1,001 - $15,000. Yield Theory keeps those ranges instead of inventing a midpoint, exact trade size, or return.

How complete is CRNX congressional-trade coverage?

This snapshot covers every machine-readable House periodic transaction report for 2025 and 2026 (142 members). Image-only filings and Senate eFD filings are not included, so missing rows are not proof that no other lawmaker traded CRNX.

Yield Theory is not affiliated with any elected official. This page uses the 2025–2026 House Clerk periodic report snapshot generated 2026-09-20. It is not a complete lifetime portfolio, a performance track record, or investment advice.

A disclosure is not a thesis.

This page shows who reported CRNX and in what range. Membership is the monthly sourced call, plus a five-minute check when the evidence moves. $15/month or $150/year.

$15/mo or $150/yr · cancel future renewals anytime · sources included